NDC 0641-6217

ROBAXIN

Methocarbamol

ROBAXIN is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceuticals Corp.. The primary component is Methocarbamol.

Product ID0641-6217_ba623e20-749a-4289-8886-d0a1eb1ffd77
NDC0641-6217
Product TypeHuman Prescription Drug
Proprietary NameROBAXIN
Generic NameMethocarbamol
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2017-10-17
Marketing CategoryNDA / NDA
Application NumberNDA011790
Labeler NameWest-Ward Pharmaceuticals Corp.
Substance NameMETHOCARBAMOL
Active Ingredient Strength100 mg/mL
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0641-6217-25

25 VIAL in 1 CARTON (0641-6217-25) > 10 mL in 1 VIAL (0641-6217-01)
Marketing Start Date2017-10-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0641-6217-01 [00641621701]

ROBAXIN INJECTION
Marketing CategoryNDA
Application NumberNDA011790
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-10-17

NDC 0641-6217-25 [00641621725]

ROBAXIN INJECTION
Marketing CategoryNDA
Application NumberNDA011790
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2017-10-17

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL100 mg/mL

OpenFDA Data

SPL SET ID:a418c43a-afe8-4a19-a57a-95c8dbe3d3d8
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 238175
  • 207014

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]
    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "ROBAXIN" or generic name "Methocarbamol"

    NDCBrand NameGeneric Name
    0641-6103ROBAXINmethocarbamol
    0641-6217ROBAXINmethocarbamol
    52244-429RobaxinRobaxin
    52244-449RobaxinRobaxin
    61919-354ROBAXINROBAXIN
    80425-0021RobaxinRobaxin
    80425-0020RobaxinRobaxin
    0143-1290MethocarbamolMethocarbamol
    0143-1292MethocarbamolMethocarbamol
    0179-0092MethocarbamolMethocarbamol
    0276-0510MethocarbamolMethocarbamol
    0404-9909MethocarbamolMethocarbamol
    0440-1740Methocarbamolmethocarbamol
    0517-1825Methocarbamolmethocarbamol
    0603-4485Methocarbamolmethocarbamol
    0603-4486Methocarbamolmethocarbamol
    0615-7572Methocarbamolmethocarbamol
    0615-7573Methocarbamolmethocarbamol
    0615-8435METHOCARBAMOLMETHOCARBAMOL
    0615-8436METHOCARBAMOLMETHOCARBAMOL
    0904-7057MethocarbamolMethocarbamol
    0904-7058MethocarbamolMethocarbamol
    10135-664MethocarbamolMethocarbamol
    10135-665MethocarbamolMethocarbamol
    10544-259MethocarbamolMethocarbamol
    10544-464MethocarbamolMethocarbamol
    10544-622MethocarbamolMethocarbamol
    10544-773MethocarbamolMethocarbamol
    10544-956Methocarbamolmethocarbamol
    17511-505METHOCARBAMOLMETHOCARBAMOL
    17511-506METHOCARBAMOLMETHOCARBAMOL
    21695-078MethocarbamolMethocarbamol
    21695-079MethocarbamolMethocarbamol
    10135-722Methocarbamol Tablets, USP, 500 mgMethocarbamol
    10135-723Methocarbamol Tablets, USP, 750 mgMethocarbamol

    Trademark Results [ROBAXIN]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ROBAXIN
    ROBAXIN
    72024798 0651130 Live/Registered
    A.H. ROBINS COMPANY, INC.
    1957-02-20
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.